or Try an Advanced Search...

    Precision Medicine Stocks List

    Symbol Grade Name % Change
    FUSN A Fusion Pharmaceuticals Inc. 0.51
    GTH B Genetron Holdings Limited 0.00
    WGS B GeneDx Holdings Corp. -0.89
    STOK C Stoke Therapeutics, Inc. 10.39
    GH C Guardant Health, Inc. 4.12
    INMB C INmune Bio Inc. 8.29
    IDYA D IDEAYA Biosciences, Inc. 1.53
    PRAX D Praxis Precision Medicines, Inc. -4.14
    NTLA F Intellia Therapeutics, Inc. 1.90
    AVTX F Avalo Therapeutics, Inc. -1.98
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
    Related Stock Lists: Biology Biotechnology Medicine Cancer Disease Molecular Biology Systems Biology Biomarkers Biopharmaceutical Cancer Treatment Checkpoint Inhibitor Clinical Development Drug Discovery Emerging Technologies Evidence Based Medicine Immune System Oncology Proteins Solid Tumors Targeted Therapy

    Related ETFs - A few ETFs which own one or more of the above listed Precision Medicine stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 4.61
    SBIO D ALPS Medical Breakthroughs ETF 3.44
    GNOM D Global X Genomics & Biotechnology ETF 3.29
    MRGR D ProShares Merger ETF 2.55
    ARKK F ARK Innovation ETF 2.55
    View all Precision Medicine ETFs...
    Compare ETFs
    Compare ARKG to MRGR Compare ARKG to SBIO Compare SBIO to ARKK

        Precision Medicine Stocks Recent News

        Date Stock Title
        May 14 NTLA Intellia Therapeutics, Inc. (NTLA) Just Overtook the 50-Day Moving Average
        May 14 PRAX We're Hopeful That Praxis Precision Medicines (NASDAQ:PRAX) Will Use Its Cash Wisely
        May 13 GH Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call Transcript
        May 13 PRAX Praxis Precision Medicines GAAP EPS of -$2.84 misses by $0.75, revenue of $0.43M misses by $1.33M
        May 13 AVTX Avalo Therapeutics reports Q1 results
        May 13 AVTX Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
        May 13 PRAX Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
        May 13 NTLA Intellia Therapeutics: 3 Near-Term Pivotal In Vivo Gene Therapies
        May 12 NTLA Earnings Beat: Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
        May 11 GH Guardant Health, Inc. (NASDAQ:GH) Shares Could Be 44% Below Their Intrinsic Value Estimate
        May 11 GH Guardant Health First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 10 NTLA Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
        May 10 NTLA Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
        May 10 GH Guardant Health Inc (GH) Reports Strong Q1 2024 Earnings, Surpasses Revenue Estimates
        May 10 NTLA Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
        May 10 PRAX Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
        May 10 NTLA Intellia Therapeutics First Quarter 2024 Earnings: Beats Expectations
        May 10 FUSN Fusion Pharmaceuticals doses first subject in prostate cancer trial
        May 10 GH Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript
        May 10 NTLA Q1 2024 Intellia Therapeutics Inc Earnings Call
        Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
        Related Stock Lists: Biology Biotechnology Medicine Cancer Disease Molecular Biology Systems Biology Biomarkers Biopharmaceutical Cancer Treatment Checkpoint Inhibitor Clinical Development Drug Discovery Emerging Technologies Evidence Based Medicine Immune System Oncology Proteins Solid Tumors Targeted Therapy
        Precision Medicine

        Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient, instead of a one‐drug‐fits‐all model. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.

        More about Precision Medicine
        Browse All Tags